Yıl: 2009 Cilt: 24 Sayı: 1 Sayfa Aralığı: 48 - 52 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri

Öz:
Tamamlayıcı ve alternatif tedavi (TAT) henüz konvansiyonel tıbbın bir parçası olarak kabul edilmeyen sağlık bakım sistemleri, ürünleri ve uygulamalardır. Ancak, TAT kullanım sıklığı hem genel popülasyonda hemde kanser hastaları arasında artmaktadır. Birçok kanser hastası konvansiyonel tedavilerle birlikte, tedavi olma/sağlama, tedaviye destek olma, kanserin tekrarlamasını önleme, konvansiyonel tedaviler yerine kullanma ve son bir çare olarak TAT kullanmaktadır. Bu derlemede, kanser hastalarının TAT kullanım nedenleri ve bunu etkileyen faktörlerle ilgili bilgiler verilmektedir.
Anahtar Kelime:

Konular: Onkoloji

Reasons for use of complementary and alternative medicine in cancer patients

Öz:
Complementary and Alternative Medicine (CAM) is a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. However, prevalence of CAM use is increasing in both cancer patients and the general population. Many cancer patients use CAM to provide treatment or cure, support treatment or cure, prevent cancer and recurrence, as a substitute for conventional treatment, and as a last resort in combination with conventional medicine. The purpose of this review was to provide information regarding the reasons for CAM use in cancer patients and the associated factors.
Anahtar Kelime:

Konular: Onkoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1) Ades T, Yarbro HC. “Alternative and complementary therapies in cancer management.” In: Yarbro HC, Frogge MH, Goodman M, editors. Cancer Nursing Principles and Practice. 5th ed. 2000. p. 617-28.
  • 2) American Cancer Association. “Alternative and Complementary Methods.” http://www.cancer.org/alt _therapy/overview.html. Erişim tarihi:25.05.2008.
  • 3) National Center For Complementary and Alternetive Medicine, CAMBASICS, (http://nccam.nih.gov/ health/whatiscam). Erişim tarihi:10.06.2008.
  • 4) Rafferty AP, McGee HB, Miller CE, Reyes M. Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 2002;92(10):1598-600.
  • 5) Vallerand AH, Fouladbakhsh JM, Templin T. The use of complementary/alternative medicine therapies for the self-treatment of pain among residents of urban, suburban, and rural communities. Am J Public Health 2003;93(6):923-5.
  • 6) Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health 2002;92(10):1582 91.
  • 7) McCa ffrey AM, Pugh GF, O'Connor BB. Understanding patient preference for integrative medical care: results from patient focus groups. J Gen Intern Med 2007;22(11):1500-5.
  • 8) Adams M, Jewell AP. The use of Complementary and Alternative Medicine by cancer patients. Int Semin Surg Oncol 2007 Apr 30;4:10.
  • 9) Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer 1998;83(4):777-82.
  • 10) Risberg T, Kaasa S, Wist E, Melsom H. Why are cancer patients using non proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 1997;33(4):575-80.
  • 11) Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005;16(4):655-63.
  • 12) Algier LA, Hanoglu Z, Ozden G, Kara F. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs 2005;9(2):138-46.
  • 13) Kav S, Hanoğlu Z, Algıer L. Türkiyede kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: Literatür taraması. Uluslararası Hematoloji-Onkoloji Dergisi 2008;18(1):32-8.
  • 14) Deng G, Cassileth BR. To what extent do cancer patients use complementary and alternative medicine? Nat Clin Pract Oncol 2005;2(10):496-7.
  • 15) Molassiotis A, Cawthorn A, Mackereth AP. “Complementary and alternative therapies” nursing patients with cancer, In: Kearney N, Richardson A, editors. Principles and Practice. Elsevier Churchill Livingstone, Fist Published, Sdney Toronto: 2006. p. 381-97.
  • 16) Tatsumura Y, Maskarinec G, Shumay DM, Kakai H. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients. Altern Ther Health Med 2003;9(3):64-71.
  • 17) Mansky PJ, Wallerstedt DB. Complementary medicine in palliative care and cancer symptom management. Cancer J 2006;12(5):425-31.
  • 18) Corner J, Harewood J. Exploring the use of complementary and alternative medicine by people with cancer. Nurs Times Res 2004;9(2):101-9.
  • 19) Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/ alternative medicine use among men with prostate cancer. Integr Cancer Ther 2005;4(2):187-94.
  • 20) Shumay DM, Maskarinec G, Kakai H, Gotay CC; Cancer Research Center of Hawaii. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract 2001;50(12):1067.
  • 21) Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, et al. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol 2005;44(2):161-7.
  • 22) Ceylan S, Hamzaoğlu O, Kömürcü S, Beyan C, Yalçin A. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med 2002;10(2):94-9.
  • 23) Montbriand MJ. Decision tree model describing alternate health care choices made by oncology patients. Cancer Nurs 1995;18(2):104-17.
  • 24) Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology 2002;11(3):212-20.
  • 25) Gözüm S, Arikan D, Büyükavci M. Complementary and alternative medicine use in pediatric oncology patients in eastern Turkey. Cancer Nurs 2007;30(1):38-44.
  • 26) Cindy Wang SY, Yates P. Nurses' responses to people with cancer who use complementary and alternative medicine. Int J Nurs Pract 2006;12(5):288-94.
  • 27) Tovey P, Broom A. Oncologists' and specialist cancer nurses' approaches to complementary and alternative medicine and their impact on patient action. Soc Sci Med 2007;64(12):2550-64.
  • 28) Beijnen JH, Schellens JH. Drug interactions in oncology. Lancet Oncol 2004;5(8):489-96.
  • 29) http://www.ukdk.org/pdf/kitap/38.pdf Topuz E. Tamamlayıcı ve Alternatif Tıp: Onkoloji Tedavisindeki Güncel Durum. Erişim tarihi:12. 06. 2008.
  • 30) Verhoef MJ, White MA. Factors in making the decision to forgo conventional cancer treatment. Cancer Pract 2002;10(4):201-7.
APA ozcelik h, Fadiloglu C (2009). Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. , 48 - 52.
Chicago ozcelik hanife,Fadiloglu Cicek Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. (2009): 48 - 52.
MLA ozcelik hanife,Fadiloglu Cicek Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. , 2009, ss.48 - 52.
AMA ozcelik h,Fadiloglu C Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. . 2009; 48 - 52.
Vancouver ozcelik h,Fadiloglu C Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. . 2009; 48 - 52.
IEEE ozcelik h,Fadiloglu C "Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri." , ss.48 - 52, 2009.
ISNAD ozcelik, hanife - Fadiloglu, Cicek. "Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri". (2009), 48-52.
APA ozcelik h, Fadiloglu C (2009). Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. Türk Onkoloji Dergisi, 24(1), 48 - 52.
Chicago ozcelik hanife,Fadiloglu Cicek Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. Türk Onkoloji Dergisi 24, no.1 (2009): 48 - 52.
MLA ozcelik hanife,Fadiloglu Cicek Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. Türk Onkoloji Dergisi, vol.24, no.1, 2009, ss.48 - 52.
AMA ozcelik h,Fadiloglu C Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. Türk Onkoloji Dergisi. 2009; 24(1): 48 - 52.
Vancouver ozcelik h,Fadiloglu C Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri. Türk Onkoloji Dergisi. 2009; 24(1): 48 - 52.
IEEE ozcelik h,Fadiloglu C "Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri." Türk Onkoloji Dergisi, 24, ss.48 - 52, 2009.
ISNAD ozcelik, hanife - Fadiloglu, Cicek. "Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri". Türk Onkoloji Dergisi 24/1 (2009), 48-52.